The current valuation score of XBiotech Inc is 7.64, ranking 215 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.75, which is -14.10% below the recent high of -1.51 and -474.65% above the recent low of -10.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.